Drug repurposing for COVID-19: Approaches, challenges and promising candidates

10.1016/j.pharmthera.2021.107930

Saved in:

Bibliographic Details
Main Authors:	Ng, Yan Ling, Salim, Cyrill Kafi, Chu, Justin Jang Hann
Other Authors:	MICROBIOLOGY AND IMMUNOLOGY
Format:	Review
Language:	English
Published:	PERGAMON-ELSEVIER SCIENCE LTD 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy COVID-19 Drug Repurposing Emerging Viruses Antivirals Clinical Trials IDENTIFICATION CORONAVIRUS DISCOVERY SARS-COV-2 INHIBITORS CANCER REPLICATION INFECTION OUTCOMES ACE2
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235430
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-235430
record_format	dspace
spelling	sg-nus-scholar.10635-2354302024-03-27T08:01:21Z Drug repurposing for COVID-19: Approaches, challenges and promising candidates Ng, Yan Ling Salim, Cyrill Kafi Chu, Justin Jang Hann MICROBIOLOGY AND IMMUNOLOGY Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy COVID-19 Drug Repurposing Emerging Viruses Antivirals Clinical Trials IDENTIFICATION CORONAVIRUS DISCOVERY SARS-COV-2 INHIBITORS CANCER REPLICATION INFECTION OUTCOMES ACE2 10.1016/j.pharmthera.2021.107930 PHARMACOLOGY & THERAPEUTICS 228 2022-12-08T10:05:09Z 2022-12-08T10:05:09Z 2021-06-28 2022-12-08T05:52:54Z Review Ng, Yan Ling, Salim, Cyrill Kafi, Chu, Justin Jang Hann (2021-06-28). Drug repurposing for COVID-19: Approaches, challenges and promising candidates. PHARMACOLOGY & THERAPEUTICS 228. ScholarBank@NUS Repository. https://doi.org/10.1016/j.pharmthera.2021.107930 0163-7258 1879-016X https://scholarbank.nus.edu.sg/handle/10635/235430 en PERGAMON-ELSEVIER SCIENCE LTD Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy COVID-19 Drug Repurposing Emerging Viruses Antivirals Clinical Trials IDENTIFICATION CORONAVIRUS DISCOVERY SARS-COV-2 INHIBITORS CANCER REPLICATION INFECTION OUTCOMES ACE2
spellingShingle	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy COVID-19 Drug Repurposing Emerging Viruses Antivirals Clinical Trials IDENTIFICATION CORONAVIRUS DISCOVERY SARS-COV-2 INHIBITORS CANCER REPLICATION INFECTION OUTCOMES ACE2 Ng, Yan Ling Salim, Cyrill Kafi Chu, Justin Jang Hann Drug repurposing for COVID-19: Approaches, challenges and promising candidates
description	10.1016/j.pharmthera.2021.107930
author2	MICROBIOLOGY AND IMMUNOLOGY
author_facet	MICROBIOLOGY AND IMMUNOLOGY Ng, Yan Ling Salim, Cyrill Kafi Chu, Justin Jang Hann
format	Review
author	Ng, Yan Ling Salim, Cyrill Kafi Chu, Justin Jang Hann
author_sort	Ng, Yan Ling
title	Drug repurposing for COVID-19: Approaches, challenges and promising candidates
title_short	Drug repurposing for COVID-19: Approaches, challenges and promising candidates
title_full	Drug repurposing for COVID-19: Approaches, challenges and promising candidates
title_fullStr	Drug repurposing for COVID-19: Approaches, challenges and promising candidates
title_full_unstemmed	Drug repurposing for COVID-19: Approaches, challenges and promising candidates
title_sort	drug repurposing for covid-19: approaches, challenges and promising candidates
publisher	PERGAMON-ELSEVIER SCIENCE LTD
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/235430
_version_	1795301941214969856

Drug repurposing for COVID-19: Approaches, challenges and promising candidates

Similar Items